[PDF][PDF] COVID‐19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre‐COVID‐19 ARDS

PG Gibson, L Qin, SH Puah - The Medical Journal of Australia, 2020 - mja.com.au
PG Gibson, L Qin, SH Puah
The Medical Journal of Australia, 2020mja.com.au
“This disease is still too strange to us, and there are too many doubts”, says Dr Ling Qin
(LQ), after reviewing more than 400 patients with coronavirus disease 2019 (COVID-19)
pneumonia in Wuhan Union Hospital, China. COVID-19 is a novel disease. We are familiar
with acute respiratory distress syndrome (ARDS); however, when it occurs as part of COVID-
19, it has different features and there remain unanswered questions. So if someone has
COVID-19 ARDS, how does it compare and contrast with ARDS from other causes? To …
“This disease is still too strange to us, and there are too many doubts”, says Dr Ling Qin (LQ), after reviewing more than 400 patients with coronavirus disease 2019 (COVID-19) pneumonia in Wuhan Union Hospital, China. COVID-19 is a novel disease. We are familiar with acute respiratory distress syndrome (ARDS); however, when it occurs as part of COVID-19, it has different features and there remain unanswered questions.
So if someone has COVID-19 ARDS, how does it compare and contrast with ARDS from other causes? To answer this question we provide a summary of the published literature (based on a PubMed search using the terms “COVID-19” and “ARDS”, 17 April 2020) and current clinical experience from managing patients with COVID-19 ARDS in Singapore (SHP) and Wuhan (LQ).
mja.com.au